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Spatial Reorganization of Saccharomyces cerevisiae Enolase To Alter
Carbon Metabolism under Hypoxia
Natsuko Miura,a Masahiro Shinohara,a Yohei Tatsukami,a Yasuhiko Sato,b Hironobu Morisaka,a,c Kouichi Kuroda,a Mitsuyoshi Uedaa,c
Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Sakyo-ku, Kyoto, Japana; Carl Zeiss Microscopy Co., Ltd., Shinjuku-ku, Tokyo, Japanb;
Industrial Technology Center, Kyoto Municipal Industrial Research Institute, Shimogyo-ku, Kyoto, Japanc
Hypoxia has critical effects on the physiology of organisms. In the yeast Saccharomyces cerevisiae, glycolytic enzymes, including
enolase (Eno2p), formed cellular foci under hypoxia. Here, we investigated the regulation and biological functions of these foci.
Focus formation by Eno2p was inhibited temperature independently by the addition of cycloheximide or rapamycin or by the
single substitution of alanine for the Val22 residue. Using mitochondrial inhibitors and an antioxidant, mitochondrial reactive
oxygen species (ROS) production was shown to participate in focus formation. Focus formation was also inhibited temperature
dependently by an SNF1 knockout mutation. Interestingly, the foci were observed in the cell even after reoxygenation. The meta-
bolic turnover analysis revealed that [U-13C]glucose conversion to pyruvate and oxaloacetate was accelerated in focus-forming
cells. These results suggest that under hypoxia, S. cerevisiae cells sense mitochondrial ROS and, by the involvement of SNF1/
AMPK, spatially reorganize metabolic enzymes in the cytosol via de novo protein synthesis, which subsequently increases car-
bonmetabolism. The mechanismmay be important for yeast cells under hypoxia, to quickly provide both energy and substrates
for the biosynthesis of lipids and proteins independently of the tricarboxylic acid (TCA) cycle and also to fit changing
environments.
Hypoxia is a condition of inadequate oxygen supply. Manystudies define hypoxia at2 mg/liter dissolved oxygen (DO)
in awater environment (1, 2). Inmammalian culture cells, 1%and
21% atmospheric oxygen are considered to be hypoxia and nor-
moxia, respectively (3, 4). Hypoxia in mammalian cells in vivo
often occurs when the oxygen supply is limited (5) and has been
reported to correlate with many diseases, including heart attack,
cancer, and stroke (6). In response to hypoxia, some tumor cells
were shown to gain increased metastatic activity (7), radiation
resistance (8), and drug resistance (9). Responses of yeast cells to
hypoxia have also attracted attention, because they are important
in infections by pathogenic fungi such as Candida albicans (10)
and Aspergillus fumigatus (11). Under hypoxia, mammalian and
yeast cells share common sensing mechanisms and physiological
responses to some extent (12). Hypoxia induces the release of
reactive oxygen species (ROS) from mitochondria via the partic-
ipation of complex III (13). The mechanisms of ROS generation
under hypoxia, although not completely understood, are known
to depend on a proton gradient across the inner mitochondrial
membrane (14). In addition to activating hypoxia-responsive el-
ement-regulated genes in the nucleus (14), ROS also triggers the
AMP-activated protein kinase (AMPK) signaling pathway (15–
18) independently of the cellular AMP/ATP ratio (19).
Under hypoxia, mammalian and yeast cells produce energy
and substrates for glycolysis-dependent biosynthesis (4, 20). Spe-
cifically, in response to hypoxia,mammalian culture cells produce
increased amounts of amino acids, fatty acids, and phospholipids,
in addition to lactate (4, 21), whereas Saccharomyces cerevisiae
cells produce increased amounts of ethanol, glycerol, succinate,
and alanine (22, 23) as the end products of glycolysis. The produc-
tion of pyruvate, which is associated with the synthetic pathways
of fatty acids, nucleotides, and other amino acids (24), is necessary
for cell growth under hypoxia.
For the rapid production of glycolytic end products, the assem-
bly of glycolytic enzymes into a complex has been considered to be
effective (25, 26), in addition to the transcriptional regulation.
Indeed, the specific intracellular localization of glycolytic enzymes
has been reported in some organisms and cells. In a few protozoan
species, including Trypanosoma brucei, glycolytic enzymes are
contained in the membrane-enclosed organelle called the glyco-
some (27, 28). Some glycolytic enzymes, such as GAPDH (glycer-
aldehyde-3-phosphate dehydrogenase), aldolase, and lactate de-
hydrogenase, have been found to be associated with the
cytoskeleton (29, 30), erythrocytemembrane (31),muscle (32), or
each other (33–35). The association of glycolytic enzymes has
been considered to contribute to metabolic efficiency by increas-
ing pyruvate production (25, 26); however, this notion is still un-
der debate (36, 37). To date, the regulation of metabolic pathways
via the association of metabolic enzymes has been found only in
plants, in which 10 glycolytic enzymes were identified to be asso-
ciated with mitochondria for supporting respiration (38, 39).
An intracellular assembly of a glycolytic enzyme under hypoxia
was recently reported in mammalian cells; that is, the glycolytic
enzymeGAPDHconjugatedwith green fluorescent protein (GFP)
was found to formfluorescent foci under hypoxia (40). Given that
changes in carbon metabolism under hypoxia have been reported
(4, 41, 42), the regulation of metabolic pathways by the spatial
reorganization of glycolytic enzymes under hypoxia is plausible.
In S. cerevisiae, 203 proteins, including heat shock proteins, have
been shown to change their cellular localization under hypoxia
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(43). In those experiments, a hypoxic conditionwas achievedwith
95% N2 and 5% H2. Although localization changes of glycolytic
enzymes in hypoxic yeast cells have never been reported, it is
nonetheless possible that glycolytic enzymes change their localiza-
tion under hypoxia as a result of excess CO2 during fermentation
(44, 45).
Spatial reorganization of proteins and organelles is often a sign
of unexpected phenomena in the cell. Some researchers have
found novel phenomena by tracking the fluorescence of protein-
conjugated GFP (46). For example, in several organisms, the syn-
thesis of purine and CTP is promoted by the formation of protein
complexes (47–50). We previously found that recombinant en-
hanced GFP (EGFP) conjugated with N-terminal amino acid res-
idues (aa 1 to 28) of yeast enolase (Eno2p) can form fluorescent
foci in the cell (51). We speculated that the N-terminal (1 to 28)
amino acid sequence might be the region regulating the intracel-
lular localization of Eno2p. Full-length Eno2p conjugated with
EGFP was localized uniformly in cells grown in an aerobic culture
(51). If the N-terminal region of Eno2p participates in its localiza-
tion, full-length Eno2p conjugated with fluorescent proteins
would be expected to form foci under unknown environmental
stimuli or during a specific phase of the cell life cycle. Moreover,
amino acid substitutions that inhibit the focus formation by the
Eno2p N-terminal region would also inhibit the focus formation
by full-length Eno2p. The comparison of focus-forming and
-nonforming cells, in conjunction with the use of reagents that
inhibit focus formation by interfering with specific cellular pro-
cesses, may reveal the mechanisms for the regulation and biolog-
ical functions of focus formation. Here, we demonstrated hypox-
ia-triggered focus formation of Eno2p and investigated the
mechanisms for the regulation and physiological effects of spatial
reorganization of Eno2p.
MATERIALS AND METHODS
Strains andmedia. The Escherichia coliDH5 strain [F80dlacZM15
(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rK
 mK
) phoA supE44
 thi-1 gyrA96 relA1] was used as host cells in the cloning experiments.
The yeast strain BY4741 (MATa his31 leu2 met15, ura3) and the
derived deletion strains of HOG1 (hog1), SCH9 (sch9), SNF1 (snf1),
and UPC2 (upc2) were purchased from EUROSCARF (Frankfurt, Ger-
many). The yeast GFP clones (Invitrogen, Carlsbad, CA)withGFP-tagged
endogenous proteins (Eno2p, Glk1p, Pgi1p, Pfk1p, Fba1p, Tpi1p, Tal1p,
Tkl1p, Tdh3p, Pgk1p, Gpm1p, Cdc19p [Pyk1p], Pyc1p, Pdc1p, Ald6p,
Fas1p, Fas2p, and Eno1p) and the HIS3 marker in the parent BY4741
strain were used to determine changes in protein localizations. E. coli was
grown in lysogeny broth containing 1% (wt/vol) tryptone, 0.5% (wt/vol)
yeast extract, 0.5% (wt/vol) sodium chloride, and 100 g/ml ampicillin.
Yeast cells were grown in yeast extract peptone dextrose (YPD) medium
(1% [wt/vol] yeast extract, 2% [wt/vol] polypeptone, and 2% [wt/vol]
glucose), YPDG418 medium (YPD medium supplemented with 0.2
mg/ml G418 disulfate; Nacalai Tesque, Kyoto, Japan), SDCHM agar
medium (0.67% [wt/vol] yeast nitrogen base without amino acids, 2%
[wt/vol] glucose, 0.002% L-histidine-HCl, 0.003% L-methionine, 2%
Casamino Acids [BD, Franklin Lakes, NJ], and 2% [wt/vol] agar),
SDCHM medium (0.67% [wt/vol] yeast nitrogen base without amino
acids, 2% [wt/vol] glucose, 0.002% L-histidine-HCl, 0.003% L-methio-
nine, 2%Casamino Acids [BD], 50mMMES [2-(morpholino)ethanesul-
fonic acid], pH 6.0), or SCMLmedium (0.67% [wt/vol] yeast nitrogen
base without amino acids, 2% [wt/vol] glucose, 0.003% L-methionine,
0.003% L-leucine, 0.13% SD multiple drop out [-Ade, -His, -Leu, -Lys,
-Trp, -Ura; Funakoshi Co., Ltd., Tokyo, Japan], and 2% [wt/vol] agar).
Glucose solutions were added to media after autoclaving to avoid the
Maillard reaction.
Construction of plasmids. Plasmids pULI1 and pUL-ATG-EGFP
were used not only to adjust growth conditions for different cell types but
also as controls. To determine amino acid residues of Eno2p important
for focus formation, plasmids encoding Eno2p fragments as well as frag-
ments carrying alanine substitutions (see Table S1 in the supplemental
material) were constructed. iProof DNA Polymerase (Bio-Rad, Rich-
mond, CA), Ligation High (Toyobo, Tokyo, Japan), and synthetic oligo-
nucleotides (Japan Bio Services, Asaka, Japan) were used for the plasmid
construction. DNA sequencing was performed using the BigDye Termi-
nator v3.1 Cycle Sequencing kit and the ABI Prism 3100 Genetic Analyzer
(Applied Biosystems, Foster City, CA). All other chemicals were of ana-
lytical grade. Primers and restriction enzymes used are listed inTable S1 in
the supplemental material. In brief, nucleotide sequences were amplified
or mixed (for pUL-ATG-EGFP construction) and ligated with restriction
fragments of plasmids (pULSG1 [52] and pRS423 [ATCC]).
Plasmid transformation. Yeast cells were transformed with plasmids
using the Frozen-EZ Yeast Transformation II kit (Zymo Research, Or-
ange, CA) and grown on SDCHLM agar plates. Transformants were
selected as single colonies and inoculated into 10 ml of SDCHM me-
dium with 50 mM MES (pH 6.0) for preculture at 25°C with shaking. At
the late log phase, precultures were subcultured in 100 ml of SDHM
medium at an optical density at 600 nm (OD600) of 0.01 and incubated at
25°C with shaking for 24 h. Cultures were then subcultured in 100 ml of
SDCHM medium with 50 mM MES (pH 6.0) at an OD600 of 0.1 for
aerobic or semianaerobic (CO2 bubbled) cultures at indicated tempera-
tures.
Preparation of yeast genome. The Gentoru-kun High Recovery kit
(TaKaRa, Otsu, Japan) was used to extract genomic DNA of yeast GFP
clones and knockoutmutants. Resulting genome samples were used as the
templates for preparing nucleotide fragments to be transformed into cells.
Construction of GFP-encoding yeast cells. To construct a GFP clone
of ENO2 containing the V22A substitution, an ENO2 knockout strain was
constructed (see Table S1 in the supplemental material). After transfor-
mation of gene fragments, cells were grown at 25°C. Successful knockout
of ENO2 was confirmed by sequencing the genomic sequence. Oligonu-
cleotide fragments containing ENO1-GFP-HIS3 and ENO2V22A-GFP-
HIS3were prepared (see Table S1 in the supplemental material) and then
inserted into the genome of the ENO2 strain at the position of ENO2.
Yeast cells were transformed with nucleotide fragments and grown on
SCMLU agar plates. Single colonies were picked and again cultured on
SCML or SCMLU agar plates. Resulting cells were inoculated into
SDCHMmedia with 50 mMMES (pH 6.0) and cultured. Construction
of GFP-encoding yeast cells was confirmed bymicroscopic observation of
fluorescence.
Preparation of knockout mutants of GFP clones. The primers used
are listed in Table S1 in the supplemental material. The following 2meth-
ods were adopted. For the first method, KanMX4-containing gene frag-
ments were amplified from genomic DNA of yeast knockout mutant
strains and transformed into yeast GFP clones. Transformants were cul-
tivated on YPDG418 agar plates, and resulting single colonies were
again plated on SCMLUG418 agar media. For the second method,
target gene fragments conjugated with GFP-HIS3 were amplified and
transformed into knockout strains. Transformants were cultured on
SCMLU agar plates, and resulting single colonies were again plated on
the same media. Constructed yeast strains were cultured in YPDG418
liquid media and transformed with the plasmid pULI1. Transformants
were cultured on SDCHM agar plates, and the resulting colonies were
used.
Culture conditions. For aerobic cultivation, a 500-ml Erlenmeyer
flask with 100 ml of media was used. For semianaerobic cultivation, a
modified method of Katahira et al. (53) was used. In brief, culture vials
with 100 ml of media and stir bar were used. For the introduction of CO2
before cultivation, CO2 was bubbled for 2 min into culture media to
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FIG1 Focus formationby the glycolytic enzyme enolase (Eno2p)underhypoxia (see also Fig. S1 in the supplementalmaterial). (A) Illustrationof fermentation vials for
semianaerobic and anaerobic fermentative cultures. (B) Amount of luminescent dissolved oxygen (LDO) in culture medium at indicated temperatures (25, 30, and
37°C). 30 air, culturemedia at 30°Cwith aeration during culture.Data show theDO level (mean SEM;n	 3) in culturemedia.Normoxia, LDO 2mg/liter;
hypoxia, 2
 LDO 0.5 mg/liter; anoxia, LDO 0.5 mg/liter. (C) Temperature-dependent focus formation by Eno2p-GFP under hypoxia. Values represent
Miura et al.













remove DO. To provide air in the culture vial, a small air pump (Ei-
bukubuku set; Kotobuki-kogei, Matsubara, Japan) equipped with a nee-
dle-connected tube was used. Yeast cells were cultivated at indicated tem-
peratures with stirring at 130 rpm.
pH and DO measurement. pH measurement of culture media was
performed using an F-52 pH meter (Horiba, Kyoto, Japan). Time course
measurement of DO (mg/liter) was performed using a luminescent DO
(LDO) meter (HQ30d; Hach Co., Loveland, CO). Measurements were
recorded automatically every 15 min for 8 h.
Treatment of cells with reagents. Stock solutions of 100mM farnesol
(Sigma) and 1 mg/ml rapamycin (Santa Cruz Biotechnology, Santa Cruz,
CA) were prepared in ethanol. To determine whether mitochondria par-
ticipate in focus formation, stock solutions of 5 mM carbonyl cyanide
m-chlorophenylhydrazone (CCCP; Sigma) and 10 mM antimycin
(Sigma) were prepared in ethanol and added to media. Antioxidant N-
acetyl-L-cysteine (NAC; Nacalai Tesque) was directly added to media.
Fluorescence microscopy. For confocal microscopy, cells were fixed
with 4% (wt/vol) paraformaldehyde-containing phosphate-buffered sa-
line (PBS) buffer for 1 h. For the observation of foci, fixed or unfixed cells
were immediately mounted on a glass slide and observed. For confocal
microscopy, a Carl Zeiss LSM 700 laser scanning microscope (Carl Zeiss,
Oberkochen, Germany) with a 100 objective (oil immersion numerical
aperture [NA], 1.40), ZEN Software (Carl Zeiss), and Imaris Software
(Bitplane AG, Zurich, Switzerland) were used. Otherwise, an inverted
fluorescence microscope IX71 (Olympus, Tokyo, Japan) with BP 470 to
490 excitation filter and BA 510 to 550 emission filter (Olympus), as well
as a 100 objective (oil immersion NA, 1.40) and Aquacosmos software
(Hamamatsu Photonics, Hamamatsu, Japan), were used.
Measuring focus-forming cells. The proportion of focus-forming
cells was calculated as follows. More than 100 cells in total were counted
each time in two-dimensional pictures taken by an epifluorescence mi-
croscope, using Katikati Counter (GTSOFT; http://www.geocities.jp/gen
_0715/). The proportion of focus-forming cells was presented asmeans
standard errors of the means (SEM) (n  3). The significance of the
difference in the ratio of focus-forming cells was tested using the one-
shoulder t test.
FACS analysis. For fluorescence activated cell sorter (FACS) analysis,
cells were suspended in PBS (pH 7.4) and assayed immediately using a cell
sorter (JSAN; Bay Bioscience, Kobe, Japan) with the detection channel
FLT1 (535DF45). In each case, fluorescence data for 10,000 cells were
acquired.
Preparation of yeast proteins for proteomic analysis. Saccharomyces
cerevisiae strain BY4741 transformed with pYEX-ENO2G or pYEX-
ENO2V22AG was cultivated aerobically or semianaerobically at 30°C.
Cells were lysed, and proteins were extracted as follows. Briefly, 250 l of
25 mM Tris-HCl buffer (pH 7.8) was added to frozen cells. After homog-
enization (3 times) at 4,000 rpm for 60 s using glass beads (GB-05; diam-
eter, 0.5 mm; TOMY, Tokyo, Japan) and Bead Smash 12 (Wakenyaku,
Kyoto, Japan), sample solutions were centrifuged at 9,700 g at 4°C for 5
min. Supernatant aliquots (500 l) were filtrated using 0.45-m spin
column filter membranes (Durapore polyvinylidene difluoride [PVDF]
membrane; Millipore, Eschborn, Germany) and then set still on ice. Pu-
rification of proteins was carried out immediately after protein extraction
using Anti-FLAG M2 affinity gel (Sigma) and column (Poly-Prep Chro-
matography Columns; Bio-Rad) according to the manufacturer’s proto-
col. After purification, samples were washed with 20 mM triethylammo-
nium bicarbonate using the Microcon YM-3 concentrator (Millipore).
Collected proteins were reduced with 10 mM Tris(2-carboxyethyl)phos-
phine (Thermo Scientific, Bremen, Germany) for 30 min and alkylated
with 20 mM iodoacetamide (Thermo Scientific) for 60 min in the dark at
room temperature. After acetone precipitation, proteins were solubilized
in 200 mM triethylammonium bicarbonate (Sigma). Protein digestion
(trypsin/protein, 1:50) was performed overnight at 37°C, and tryptic di-
gests were applied to a proteome analysis system.
LC/MS-MS analysis andMS data analysis. Protein identification was
performedwith a liquid chromatography-tandemmass spectrometry sys-
tem (LC/MS-MS) as described elsewhere (54). Proteolytic digests were
separated by reversed-phase chromatography using the UltiMate3000
nano LC system (Dionex). A monolithic silica capillary column (200 cm
long, 0.1-mm inside diameter [i.d.]) prepared with a mixture of tetrame-
thoxysilane and methyltrimethoxysilane was used at a flow rate of 500
nl/min. The gradient was provided by changing the mixing ratio of the
two following eluents: A, 0.1% (vol/vol) formic acid; and B, 80% acetoni-
trile containing 0.1% (vol/vol) formic acid. The gradient was started with
5% B and increased to 50% B for 600 min. Separated analytes were de-
tected on an LTQ Velos linear ion trap mass spectrometer (Thermo Sci-
entific). An electrospray ionization (ESI) voltage of 2.4 kV was applied
directly to the LC buffer distal to the chromatography column using a
MicroTee (Upchurch Scientific, Oak Harbor, WA). The ion transfer tube
temperature on the LTQVelos ion trap was set to 300°C. For data-depen-
dent acquisition, the method was set to automatically analyze the 5 most
intense ions observed in the MS scan. Mass spectrometry data were used
for protein identification by theMascot search engine on Protein Discov-
erer software (Thermo Scientific) against the information in the Saccha-
romyces Genome Database (SGD; http://www.yeastgenome.org). Search
parameters for peptide identification included a precursormass tolerance
of 1.2 Da, a fragment mass tolerance of 0.8 Da, a minimum of 1 tryptic
terminus, and a maximum of 1 internal trypsin cleavage site. Cysteine
carbamidomethylation (57.021 Da) and methionine oxidation
(15.995Da)were set as differential amino acidmodifications. Datawere
then filtered at a q value of0.01, corresponding to a 1% false-discovery
rate (FDR) at the spectral level.
Extraction of cellular metabolites. Cells incubated at 30°C in 500 l
media (OD600, 8.0) containing 2% [U-
13C]glucose (U-13C6, 99%; Cam-
bridge Isotope Laboratories Inc., Andover, MA) for 0, 2, 5, and 10 min
were immediately injected into 5 ml of 60% methanol at 40°C. After
centrifugation at 5,000  g at 9°C for 5 min, supernatants were dis-
carded, and 3 ml of 75% ethanol was added. After heating at 100°C for 30
mean values of the proportion of cells with foci (% total cells) SEM (n	 3). 30°C anaerobic, cells grown at 30°C semianaerobically in culture vials; 30°C air,
cells grown at 30°C semianaerobically in culture vials with aeration; 37°C anaerobic, cells grown at 37°C semianaerobically in culture vials; 37°C air, cells grown
at 37°C semianaerobically in culture vials with aeration. ENO2-GFP/I1, the ENO2-GFP strain transformed with plasmid pULI1; ENO2::1-GFP/I1, a pULI1-
transformed strain carrying genome-integrated ENO1 conjugatedwithGFP at the position of ENO2 (ENO2::1-GFP strain). Cells were cultivated under indicated
conditions for 3, 6, 12, or 24 h and observed. (D) Determination of the focus-forming region in the Eno2p N terminus conjugated with EGFP and a FLAG tag.
pUL-eno(X-Y), cells transformed with various pUL-eno(X-Y) plasmids; pUL-eno(X–25)GGS, cells transformed with various pUL-eno(X–25)GGS plas-
mids. Cells were aerobically cultivated and observed. Highlighted pictures show cells with foci: bright red, cells with clear foci; dark red, cells with unclear foci.
(E) Single alanine substitution of N-terminal amino acids of Eno2p conjugated with EGFP and FLAG. pUL-eno(30), cells transformed with plasmid pUL-
eno(30); XxA, cells transformed with plasmids pUL-eno(30)XxA, where X indicates a single letter of amino acid residues and x indicates the position of amino
acid residues substituted with alanine. Cells were aerobically cultivated and observed. (F) Amino acid substitutions of the V22 residue. V22X, cells transformed
with plasmids pUL-eno(30)V22X, inwhich the Eno2pN-terminal (aa 1 to 30) amino acid sequences carryingV22X substitutionwere conjugatedwith EGFP and
a FLAG tag. Highlighted pictures show a cell’s successful single amino acid substitution that blocked the focus formation. (G) Inhibition of the focus formation
by substitution of alanine at residue V22. Cells were cultivated at 30°C semianaerobically for 6 h and observed. Bar, 10 m. ENO2-GFP/pULI1, the ENO2-GFP
strain transformed with pULI1; ENO2V22A-GFP/pULI1, the ENO2V22A-GFP strain transformed with pULI1. Representative data of at least 3 independent
experiments are shown.White arrowheads indicate observed foci. (H) Colocalization of foci formed by N-terminal amino acids of Eno2p and full-length Eno2p
under hypoxia. Cells were cultivated at 30°C semianaerobically for 12 h and observed. Bar, 5 m. White arrowheads indicate colocalized foci.
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min and cooling on ice and then at 40°C, cells were lyophilized and
stored at80°C. For sample preparation, 1 ml of MilliQ water and 60 l
of 0.2-mg/ml ribitol were added to lyophilized cells and heated at 37°C for
30 min in a 1.5-ml test tube. After samples were centrifuged at 16,000 g
for 5 min at 4°C, 900 l of supernatants was transferred to new tubes.
Next, 400 l of MilliQ water was added to each sample, followed by cen-
trifugation at the same rate. Finally, 400l of supernatantswas transferred
to new tubes, lyophilized, and used for the metabolite analysis.
For oximation, 100 l of 20 mg/ml methoxyamine hydrochloride
(Sigma) in pyridine (Wako, Osaka, Japan) was added and incubated at
30°C for 90 min. For trimethylsilylation, 50 l of N-methyl-N-(trimeth-
ylsilyl) trifluoroacetamide (GL Science Inc., Tokyo, Japan) was added,
followed by incubation at 37°C for 30 min. Insoluble residues were re-
moved by centrifugation at 10,000 g for 10min at 4°C, and supernatants
were transferred to clean vials.
GC/MS analysis. Cells were incubated at 30°C in 500 l of media
(OD600, 8.0) containing 2% [U-
13C]glucose (Cambridge Isotope Labora-
tories Inc., Andover, MA) for 0, 2, 5, and 10 min. Cellular metabolites
extracted using modifiedmethods of Mashego et al. (55) were derivatized
as previously described (56). Derivatizedmetabolites were analyzed using
a GCMS-QP2010 Ultra (Shimadzu, Kyoto, Japan) equipped with a 30-m
by 0.25-m (i.d.) fused silica capillary column coated with 0.25-m CP-
SIL 8 CB low bleed (Agilent Technologies, Palo Alto, CA). Aliquots (1l)
were injected in a split mode (25/1) at 230°C using helium as the carrier
gas at a flow rate of 1.12ml/min. The column temperaturewasmaintained
isothermally at 80°C for 2 min, raised to 130°C at a rate of 4°C/min and
then to 330°C at a rate of 25°C/min, and maintained for 6 min isother-
mally. Temperatures of the interface and MS were 250°C and 200°C, re-
spectively, and ion voltage was 1 kV. Data were collected by GC-MS solu-
tion software (Shimadzu), and identified metabolites are shown in Table
S2 in the supplemental material. Mass isotopomer distributions were cor-
rected for natural isotope abundance as previously described (57).
Protein structure accession number. The data determined in this
study have been deposited in the ProteomeXchange Consortium (http:
//proteomecentral.proteomexchange.org) via the PRIDE partner reposi-
tory (58) with the data set identifier PXD000173.
RESULTS
V22 residue-dependent focus formation by full-length Eno2p
under hypoxia. Fermentation vials were used to culture cells un-
der semianaerobic conditions (hypoxia) (Fig. 1A). During culti-
vation, pH did not fall below 5 (see Fig. S1A in the supplemental
material), whereas the amount of DO decreased with time
(Fig. 1B). At 30°C, DO in the culturemedia decreased to a hypoxic
level within 6 h (Fig. 1B). We found that a GFP clone, in which
ENO2was fusedwithGFP (strain ENO2-GFP), formed foci under
the semianaerobic condition after 6 h of culture in vials at 30°C. At
37°C, foci were formed after 3 h of culture in vials, but at 25°C, foci
were not observed after 24 h of culture (Fig. 1C; see Fig. S1B and C
in the supplemental material). When air was introduced into the
vial, foci were not observed at 30°C but were observed at 37°C
(Fig. 1C; see Fig. S1D in the supplemental material). When cells
were observed two-dimensionally, the maximum ratio of focus-
forming cells was around 35% (Fig. 1C), whereas almost all the
cells were found to form GFP foci when being observed three-
dimensionally, as the number of foci formed by strain ENO2-GFP
and DAPI (4=,6-diamidino-2-phenylindole) were 143 and 147,
respectively (see Movie S1 in the supplemental material).
To determine the key region and residue of Eno2p for focus
formation, the N-terminal focus-forming Eno2p region (51) was
investigated. We found that the shortest focus-forming region of
N-terminal Eno2p fused with EGFP included amino acid residues
5 to 25 (Fig. 1D). The N-terminal region of Eno2p forms con-
served -hairpin-like structure, in which R9, E21, E23, and V22
residues seem to stack the -hairpin (see Fig. S1E in the supple-
mental material). We speculated that the conserved structure
might have a role in forming foci. When alanine replacements
were introduced in amino acid residues 6 to 25, substitutions at
V22 inhibited the focus formation (Fig. 1E). Replacement of V22
with P, E, D, S, T, R, H, K, or N also inhibited the focus formation
by the N-terminal region; in contrast, substitution of L, I, W, or Y
conserved foci (Fig. 1F). To determine whether the V22 residue is
necessary for the focus formation, conservation of the focus-
forming ability of the N-terminal region was further investigated.
The N-terminal region of Eno2p is conserved across species (see
Fig. S1F in the supplemental material). In Escherichia coli enolase,
although V22 is not conserved, its N-terminal region still exhib-
ited the focus-forming ability (see Fig. S1G in the supplemental
material). In the case of mouse - and -enolase, the focus-form-
ing ability was lost, althoughV22 residueswere conserved (see Fig.
S1F and G in the supplemental material). Interestingly, mouse
-enolase retained the focus-forming ability (see Fig. S1G in the
supplemental material). Taken together, these results suggest that
the focus-forming ability of the N-terminal region of S. cerevisiae
Eno2p is conserved across species and is not always dependent
on V22.
To test whether the V22 residue contributes to the focus for-
mation of full-length Eno2p, a single alanine substitution for the
Eno2pV22 residuewas introduced into the ENO2-GFP strain (see
Table S1 in the supplementalmaterial). After 6 h of culture in vials
at 30°C or 37°C, the V22A mutant of ENO2-GFP (ENO2V22A-
GFP strain) did not form foci (Fig. 1C andG). The fluorescent foci
formed byDsRed-conjugatedN-terminal Eno2p were colocalized
with foci of the ENO2-GFP strain at 30°C after 12 h of fermenta-
tive culture (Fig. 1H), indicating the similar localization of foci
formed by both full-length Eno2p and its N-terminal region.
These results suggest that Eno2p-dependent focus formation
in yeast cells depended on not only the V22 residue but also cul-
ture temperatures and DO concentrations.
Investigations on the regulatory mechanisms of the focus
formation. To determine the regulatory mechanisms of the focus
formation, possible regulatory mechanisms such as protein syn-
thesis, cell signaling, mitochondrial activity, and protein associa-
tion were investigated by chemicals, gene knockouts, or pro-
teomic analysis.
(i) Temperature-independent inhibition of focus formation
by cycloheximide and rapamycin.To determine themechanisms
for the regulation of focus formation, several reagentswere used to
inhibit the focus formation.We demonstrated that cycloheximide
blocked the focus formation by the ENO2-GFP strain at 30°C and
37°C in semianaerobic cultures (Fig. 2A and B), whereas rapamy-
cin at a growth-inhibiting dose hindered the focus formation at
37°C (Fig. 2C and D; see Fig. S2 in the supplemental material). In
contrast, the focus formationwasmaintainedwith the application
of a growth-inhibiting dose of farnesol, an inhibitor of the cyclic
AMP (cAMP), protein kinase A (PKA), and mitogen-activated
protein kinase (MAPK) signaling pathways in C. albicans (59–62)
and a mitochondrial ROS generator (63) and a growth inhibitor
(64) in S. cerevisiae (Fig. 2C and E; see Fig. S2 in the supplemental
material). These results suggest the DO-independent participa-
tion of both the de novo protein synthesis and TORC1-dependent
regulation at 37°C in the focus formation.
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(ii) Identification of SNF1 as a regulator of focus formation
at 30°C. To determine the signaling pathway regulating the focus
formation, knockout mutations of genes participating in various
signaling pathways, namely, HOG1 (MAPK pathway), SCH9
(PI3K-AKT pathway), and SNF1 (SNF1/AMPK pathway), were
introduced into the ENO2-GFP strain. In semianaerobic cultures,
the focus formation by the ENO2-GFP strain without SNF1
(SNF1 ENO2-GFP strain) was inhibited at 30°C, in contrast to
all other strains tested (Fig. 3A and B; see Fig. S3A in the supple-
mental material). To assess the involvement of Upc2p, which is a
known regulator of hypoxia-responding transcription in yeast C.
albicans (65) and S. cerevisiae (66), a UPC2 knockout mutation
was introduced in the same manner. As a result, the focus forma-
tionwas not inhibited (see Fig. S3A in the supplementalmaterial),
suggesting no involvement of Upc2p in the focus formation. In
semianaerobic cultures at 37°C, the SNF1 ENO2-GFP strain
formed foci (see Fig. S3B in the supplemental material), suggest-
ing the temperature-dependent regulation of focus formation by
SNF1. A strain carrying plasmid-reintegrated SNF1 regained the
focus-forming ability in semianaerobic cultures at 30°C (Fig. 3C),
confirming a role of SNF1 in the focus formation at 30°C. Taken
together, these results suggest that foci were formed at 30°C in
response to hypoxia via the participation of SNF1/AMPK. In gen-
eral, the optimum temperature for cultivating S. cerevisiae strain
BY4741 is 30°C. Accordingly, we focused on the focus formation
induced at 30°C under hypoxia.
(iii) Involvement ofmitochondrial ROS production in focus
formation. The involvement of mitochondrial ROS production,
which is known to activate AMPK, was investigated using mito-
chondrial inhibitors and an antioxidant. The mitochondrial un-
coupler CCCP was found to inhibit focus formation (Fig. 4A and
B), indicating mitochondrial involvement. Antimycin, which is
FIG 2 Temperature-independent inhibition of the Eno2p focus formation by chemicals (see also Fig. S2 in the supplemental material). (A) Inhibition of focus
formation by the addition of cycloheximide (CHX) at 37°C. A final concentration of 0.5 ng/ml CHXwas added to culture vials before semianaerobic cultivation.
Values represent mean values of the proportion of cells with foci (% total cells) SEM (n	 3) after 12 h of semianaerobic culture at 37°C. Data were analyzed
using Student’s t test. (B) Inhibition of focus formation by the addition of CHXat 30°C and 37°C. A final concentration of 5 ng/mlCHXwas added to culture vials
before semianaerobic cultivation at indicated temperatures. Bar, 10m. (C) Effects of rapamycin and farnesol on focus formation. Values representmean values
of the proportion of cells with foci (% total cells) SEM (n	 3) after 12 h of semianaerobic culture at 37°C. Data were analyzed using Student’s t test with the
Bonferroni correction formultiple comparisons. (D)Growth inhibition by the addition of rapamycin. Filled circle with solid line, 0 ng/ml rapamycin; open circle
with solid line, 20 ng/ml rapamycin; filled circle with dashed line, 50 ng/ml rapamycin; open circle with dashed line, 100 ng/ml rapamycin. (E) Growth inhibition
by the addition of farnesol. Filled circle with solid line, 0 mM farnesol; open circle with solid line, 0.5 mM farnesol; filled circle with dashed line, 1 mM farnesol.
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an inhibitor of mitochondrial complex III, also inhibited focus
formation (Fig. 4C and D). Importantly, the antioxidant NAC
inhibited focus formation, indicating the involvement of mi-
tochondrial ROS released into the cytoplasm under hypoxia
(Fig. 4C and D).
(iv) Detection of proteins coimmunoprecipitated with fo-
cus-forming Eno2p.To detect proteins involved in foci, an ENO2
knockout (ENO2) strain and plasmids for producing recombi-
nant Eno2p-EGFP-FLAG or its V22A mutant (Eno2V22Ap-
EGFP-FLAG) were prepared (see Table S1 in the supplemental
material). The fluorescence intensities of ENO2 strains produc-
ing recombinant proteins were comparable to those of strain
ENO2-GFP in aerobic culture (see Fig. S4A in the supplemental
material). After 12 h of semianaerobic culture, the Eno2p-EGFP-
FLAGproteinwas able to form foci (Fig. 5A). To investigate proteins
associated with focus-forming Eno2p, Eno2p-EGFP-FLAG and
Eno2V22Ap-EGFP-FLAGproteins were immunoprecipitated, and
their interacting proteins were identified by LC/MS-MS (see Fig.
S4B in the supplementalmaterial). As a result, 96 proteins, includ-
ing 35 metabolic proteins, were detected in samples coimmuno-
precipitated with Eno2p-EGFP-FLAG and Eno2V22Ap-EGFP-
FLAG (Fig. 5B, area I; see Fig. S4C and Table S3 in the
supplemental material). We also identified that 29 proteins, in-
cluding 15 metabolic proteins, were coimmunoprecipitated only
with Eno2p-EGFP-FLAG (Fig. 5B, area II; see Fig. S4D and Table
S3 in the supplemental material). Area I included 17 glycolytic
enzymes. To test whether glycolytic enzymes form foci under hyp-
oxia, individual GFP clones were used. We observed the focus
formation by glycolytic enzymes Pfk1p, Fba1p, Tpi1p, Tdh3p,
Gpm1p, and Cdc19p (Pyk1p) under hypoxia (Fig. 5C). In addi-
tion, foci formed by these glycolytic enzymes were colocalized
with foci formed by the N-terminal Eno2p (aa 1 to 28) fragment
conjugated with the DsRed monomer (Fig. 5C). Pgk1p, though
included in area I, did not form foci under hypoxia (Fig. 5C).
Among detectedmetabolic enzymes in area I, Pdc1p-GFP formed
foci under normoxia (see Fig. S4E in the supplemental material).
Among metabolic enzymes that were detected by the proteomic
analysis, GFP-conjugated Tal1p (area I) and Tkl1p (area II), en-
zymes of the pentose phosphate pathway, and Pdc1p (area I),
Ald6p (area II), Fas1p (area I), and Fas2p (area I), enzymes in-
volved in the fatty acid synthesis, were detected to form foci under
hypoxia (Fig. 5C; see Fig. S4F in the supplemental material). Foci
formed by Pdc1p, Ald6p, Fas1p, and Fas2p were colocalized with
those formed by the N-terminal Eno2p (aa 1 to 28) fragment con-
jugatedwith theDsRedmonomer (see Fig. S4F). Colocalization of
foci formed by Tkl1p and Tal1p with those formed by the N-ter-
minal Eno2p (aa 1 to 28) fragment conjugated with the DsRed
monomer was also observed; however, not all the foci were colo-
calized (see Fig. S4F). An overview of focus-forming proteins in
glycolytic pathway under hypoxia is shown in Fig. 5D.
Investigation of the effects of focus-inhibiting mutations on
the carbon metabolic pathway in hypoxia-treated cells. The
ENO2-GFP V22A mutant strain (ENO2V22A-GFP) grew slower
than the ENO2-GFP strain in semianaerobic cultures (see Fig. S5A
in the supplemental material), suggesting changes in cell metabo-
lism. After semianaerobic culture for 12 h, foci formed by the
ENO2-GFP strain were retained following 24 h of aerobic culture
in fresh media (Fig. 6A). To investigate the effects of focus forma-
tion on cellular carbonmetabolism, a metabolic turnover analysis
of strains ENO2-GFP and ENO2V22A-GFP was carried out using
[U-13C]glucose after semianaerobic (focus-forming condition) or
aerobic (focus-nonforming condition) culture (Fig. 6B). The ra-
tios of 13C-labeled pyruvate and oxaloacetate in focus-forming
cells were higher than those in focus-nonforming cells after 2 and
FIG 3 Temperature-dependent inhibition of the Eno2p focus formation in SNF1 knockout mutants (see also Fig. S3 in the supplemental material). (A)
Inhibition of focus formation in theSNF1 ENO2-GFP strain at 30°C. Plasmid pULI1-transformed cells were cultivated at 30°C semianaerobically for 12 h and
observed. Bar, 10 m. White arrowheads indicate observed foci. (B) Values represent mean values of the proportion of cells with foci (% total cells)  SEM
(n	 3) after 24 h of semianaerobic culture at 30°C. Data were analyzed using Student’s t test. (C) Compensation of the focus formation by reintroduction of
SNF1. Cells were observed after 12 h of semianaerobic culture. Bar, 10 m. Representative data of 3 independent experiments are shown. White arrowheads
indicate observed foci.
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5 min of intake (Fig. 6C). For glycerol and alanine in strain
ENO2V22A-GFP, the ratios of 13C-labeled metabolites were
slightly higher in cells grown in semianaerobic cultures, whereas
the ratios remained unchanged in strain ENO2-GFP. In both
strains, the ratios of aspartate, malate, citrate, and succinate, all of
which have 3 13C atoms, were higher in cells subjected to semian-
aerobic cultures, indicating the incorporation of oxaloacetate-de-
rived 13C into the TCA cycle (Fig. 6C; see Fig. S5B in the supple-
mental material). These results suggest that cells forming foci
accelerated the incorporation of glucose-derived 13C into pyru-
vate and oxaloacetate and preferentially produced aspartate and
malate, rather than alanine, from pyruvate. To test the involve-
ment of Pyc1p, which converts pyruvate to oxaloacetate (see Fig.
S5C in the supplemental material), the focus-forming ability of
Pyc1p under hypoxia was investigated. We observed that GFP
fused with Pyc1p formed foci under hypoxia (Fig. 6D), suggesting
the coordinated synthesis of pyruvate and oxaloacetate by focus-
forming enzymes.
DISCUSSION
Focus formation by proteins, including Eno2p, under hypoxia.
Spatial reorganization of glycolytic enzymes, including Eno2p,
was detected for the first time in S. cerevisiae under hypoxic fer-
mentation conditions. As the foci formed by full-length Eno2p
showed localization similar to those of the foci formed by the
N-terminal region of Eno2p (Fig. 1H), which colocalized with
proteins of cytoplasmic or nucleus membrane in addition to pro-
teins of the Golgi body or endosome (51), the foci formed by
Eno2p seem to localize in the cytoplasm near intracellular organ-
elles. The assembly of glycolytic enzymes via spatial reorganiza-
tion is considered to be effective for accelerating glycolysis. There-
fore, spatial reorganization of metabolic enzymes may be a novel
mechanism for efficient energy production, without the TCA cy-
cle, under hypoxia. Moreover, the novel changes in the intracel-
lular localization detected in this study may enable glycolytic pro-
teins to perform unforeseen functions in response to specific
environmental stimuli, in addition to their roles in regulating cell
FIG 4 Inhibition of focus formation by antioxidant and inhibitors of mitochondrial ROS production at 30°C. (A) Inhibition of focus formation by addition of
the mitochondrial uncoupler CCCP. A final concentration of 0 or 50 mM CCCP was added to culture vials before cultivation. Cells were cultured semianaero-
bically at 30°C for 12 h and observed. Representative data of 3 independent experiments are shown. Bar, 10 m. White arrowheads indicate observed foci. (B)
Calculation of the rate of inhibition by CCCP. Values represent mean values of the proportion of cells with foci (% total cells)  SEM (n 	 3) after 12 h of
semianaerobic culture at 30°C. Data were analyzed using Student’s t test with the Bonferroni correction for multiple comparisons. (C) Effects of the mitochon-
drial inhibitor NAC and the antioxidant antimycin on focus formation. After the addition of specific reagents, cells were semianaerobically cultured at 30°C for
12 h and observed. Representative data of at least 3 independent experiments are shown. Bar, 10m.White arrowheads indicate observed foci. DMSO, dimethyl
sulfoxide. (D) Calculation of the inhibition rate by NAC and antimycin. Values represent mean values of the proportion of cells with foci (% total cells) SEM
(n	 3) after 12 h of semianaerobic culture at 30°C. Data were analyzed using Student’s t test.
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FIG 5 Detection of focus-forming metabolic proteins under hypoxia (see also Fig. S4 and Table S3 in the supplemental material). (A) Focus formation by
plasmid-introduced recombinant Eno2p. The ENO2 strain transformed with various plasmids was semianaerobically cultured at 30°C for 12 h and observed.
pYEX-ATG-EGFP, the plasmid used for producing EGFP-FLAG tag; pYEX-ENO2G, the plasmid for producing Eno2p conjugated with the EGFP-FLAG tag;
pYEX-ENO2V22AG, the plasmid for producing the Eno2p V22A mutant conjugated with the EGFP-FLAG tag. Bar, 10 m. Representative data of at least 3
independent experiments are shown. White arrowheads indicate observed foci. (B) Overview of identified proteins coimmunoprecipitated with recombinant
Eno2p-EGFP-FLAG and Eno2V22Ap-EGFP-FLAG. Before protein extraction, cells were cultured for 12 h at 30°C semianaerobically. Data represent 2 biological
replicates and 2 technical replicates (n	 4). I, 96 proteins coimmunoprecipitated with recombinant Eno2p-EGFP-FLAG and Eno2V22Ap-EGFP-FLAG; II, 29
proteins coimmunoprecipitated with recombinant Eno2p-EGFP-FLAG; III, 16 proteins coimmunoprecipitated with recombinant Eno2V22Ap-EGFP-FLAG.
(C) Focus formation bymetabolic enzymes and their colocalization with foci formed by N-terminal amino acid sequences conjugated with DsRed. Various GFP
strains (of Pfk1p, Fba1p, Tpi1p, Tdh3p, Pgk1p, Gpm1p, and Pyk1p) or strain BY4741 transformed with the plasmid pULR-eno(1-28) were cultured semian-
aerobically at 30°C for 12 h and observed. Eno(1-28)-DsRed, red fluorescence from the N-terminal (aa 1 to 28) amino acid sequence of Eno2p conjugated with
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metabolism. It is also noteworthy that many metabolic enzymes
were coimmunoprecipitated with Eno2p-EGFP-FLAG-formed
foci under hypoxia (Fig. 1H, 5C, and 6D; see Fig. S4F and Table S3
in the supplemental material); these enzymes are involved in the
pentose phosphate pathway, fatty acid synthesis, tRNA synthesis,
and amino acid synthesis. It is possible that the flow rate of each
metabolic pathway may be regulated via the control of spatial
reorganization of proteins, in addition to the modulation of the
amount of proteins. Of the detected proteins, some have roles in
protein transport (see Table S3 in the supplemental material),
indicating that the spatial reorganization of glycolytic enzymes is
possibly regulated by these proteins. Given that S. cerevisiae has
many biological processes in commonwith other eukaryotic cells,
these mechanisms may be conserved across species.
Importance of single amino acids in Eno2p for focus forma-
tion. The colocalization of foci formed by full-length Eno2p-GFP
and anN-terminal fragment fused with DsRed (Fig. 1H) supports
our speculation that an N-terminal focus-forming region regu-
lates spatial reorganization of full-length Eno2p. Amino acids V, I,
L, Y, andWhave also been reported to be important for the stack-
ing of -hairpin structures of tau proteins (67). Accordingly, the
three-dimensional structure of the Eno2p N-terminal region
might be important for focus formation.We conclude that spatial
reorganization by the specific amino acid sequence of Eno2p may
promote spatial reorganization of the whole protein. Screening
peptide sequences would be a useful approach for discovering
such amino acid sequences in other focus-forming proteins under
hypoxia.
Focus formation by Eno2p in response to ROS produced by
hypoxicmitochondria, SNF1/AMPK, TORC1, and de novo pro-
tein synthesis. The temperature-independent inhibition of focus
formation by cycloheximide suggests that de novo protein synthe-
sis is an important factor, in addition to the regulation by the
signaling pathway. While the inhibition of focus formation by
rapamycin was also temperature independent, the rapamycin
doses that blocked the focus formation were found to inhibit cell
growth. However, considering that the focus formation was not
hindered when farnesol was added at a growth-inhibiting dose,
TORC1 incorporation is still important. The finding that HOG1
and SCH9 knockout failed to inhibit the focus formation is rea-
sonable, because farnesol was reported to be an inhibitor of the
MAPK and PKC/Akt pathways in the pathogenic fungus C. albi-
cans (65).
The inhibition of focus formation by knocking out SNF1 was
unexpected, because the SNF1/AMPK pathway is known to be
activated by a glucose-limiting state, in which glycolytic enzymes
are downregulated.However, the inhibition of focus formation by
mitochondrial inhibitors and an antioxidant supports the in-
volvement of SNF1/AMPK in hypoxia-responsive focus forma-
tion. The focus formation was strongly dependent on tempera-
tures and decreased DO in culture media. Together, these results
suggest that the focus formation by Eno2p was dependent on
more than 1 pathway (Fig. 7). AlthoughAMPK is known to inhibit
the TOR pathway, there are some instances in which both the
AMPK and TOR pathways regulate cell physiology (68, 69). For
example, in S. cerevisiae, both Snf1p and TORC1 have been sug-
gested to have roles in regulating fatty acids via unknown mecha-
nisms (70). Such unknown regulatory mechanisms for these 2
pathways may be revealed by future studies.
The detailed mechanisms that enable rapid focus formation at
higher temperature (37°C) should also be revealed by future stud-
ies. One possible explanation may be that increased amount of
mitochondrial ROS was produced at higher temperature via in-
creased mitochondrial transport chain activity, as previously re-
ported (71–73).
Shifting the carbon metabolic pathway by spatial reorgani-
zation.Given that the glycolytic pathway hasmany branches con-
nected to various metabolic pathways, including the synthesis of
nucleotides, amino acids, and lipids, and to energy production,
the effective use of carbon sources according to cellular needs
in the struggle for survival is expected to be extremely important.
The regulation of the carbon metabolic pathway has been re-
ported to be accomplished by the transcriptional modulation of
various regulators (74–77). However, it has never been reported
that the central carbon metabolic pathway may be regulated by
spatial reorganization or association of glycolytic enzymes in vivo.
The focus formation by GFP-conjugated Eno2p and other gly-
colytic enzymes (Glk1p, Pgi1p, Pfk1p, Fba1p, Tpi1p, Tdh3p,
Gpm1p, and Pyk1p) under hypoxia (Fig. 1H and 5C, D, and E; see
Fig. S4F in the supplemental material) and their colocalization
with foci formed by N-terminal Eno2p (Fig. 5C) suggest the com-
plex formation of glycolytic enzymes in the cytosol. As predicted
by a simulation study of glycolytic flux, under focus-forming con-
ditions, the incorporation of glucose-derived 13C into pyruvate
and oxaloacetate was accelerated. The inhibition of focus forma-
tion by introducing the V22A mutation and its metabolic turn-
over analysis demonstrated the participation of Eno2p focus
formation in controlling carbon metabolism. Moreover, the in-
creased ratios of 13C-labeled pyruvate, oxaloacetate, aspartate,
malate, citrate, and succinate in focus-forming cells suggest that
foci participate in increasing the flux of pyruvate and oxaloacetate
synthesis, at the same time increasing the synthesis of the other
metabolites. Taken together, these results support the hypothesis
that under hypoxia, certain glycolytic enzymes are spatially reor-
ganized to alter the carbon metabolic pathway. Fluxes and con-
centrations of metabolites in glycolysis are rapid and small, re-
spectively, especially in reactions catalyzed by Eno2p, even though
Eno2p is one of the most abundant proteins in a cell. However,
changing the amount of Eno2p seems to have no significant effect
on cell metabolism, as indicated by previous results in E. coli (78).
In S. cerevisiae, the amounts of Eno2p and other glycolytic en-
zymes under hypoxia were reported to be increased significantly
(79). Based on these observations, forming a complex of meta-
the DsRed monomer (shown in magenta); GFP, green fluorescence from the proteins conjugated with GFP. Bar, 5 m. White arrowheads indicate colocalized
foci (shown in white). (D) Overview of focus-forming proteins in glycolytic pathway under hypoxia. Green or gray characters indicate enzymes that formed or
did not form, respectively, foci under hypoxia. (E) Focus formation by metabolic enzymes under hypoxia. Various GFP strains (of Glk1p, Pgi1p, Pfk1p, Fba1p,
Tpi1p, Tdh3p, Pgk1p, Gpm1p, Pyk1p, Tal1p, Tkl1p, Pdc1p, Ald6p, Fas1p, Fas2p, and Pyc1p) transformed with the plasmid pULI1 were cultured semianaero-
bically at 30°C for 12 h (for Pfk1p, Fba1p, Tpi1p, Tdh3p, Pgk1p, Gpm1p, Pyk1p, Tal1p, Tkl1p, Pdc1p, Fas1p, Fas2p, and Pyc1p) or 24 h (for Pgi1p, Glk1p, and
Ald6p) and observed. Bar, 10 m. Green or gray characters indicate enzymes that formed or did not form, respectively, foci under hypoxia.
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FIG 6 Changes in the carbon metabolic pathway of focus-forming cells (see also Fig. S5 in the supplemental material). (A) Conservation of foci after
semianaerobic culture. Cells were cultivated semianaerobically at 30°C for 12 h, collected, and suspended in fresh media to an OD600 of 8.0 (green line), 4.0 (red
line), or 1.0 (blue line), followed by aerobic cultivation at 25°C for 12 and 24 h. Values represent mean values of the proportion of cells with foci (% total cells)
SEM (n	 3). (B) Scheme for the measurement of 13C incorporated in metabolites. (C) Incorporation of glucose-derived 13C into metabolites of focus-forming
and -nonforming cells. Values represent mean values of 3 (for glycerol) or 4 (for other metabolites) biological replicates SEM (n	 3 or 4). ENO2-GFP/I1, the
ENO2-GFP strain transformed with pULI1; ENO2V22A-GFP/I1, the ENO2V22A-GFP strain transformed with pULI1. Magenta and gray lines, metabolites
extracted from cells after semianaerobic culture and after aerobic culture, respectively. x axis, labeled fraction; y axis, time (min). (D) Focus formation by
PYC1-GFP under hypoxia. The PYC1-GFP strain transformed with pULI1 was cultured semianaerobically at 30°C for 12 h and observed. Bar, 5 m. White
arrowheads indicate colocalized foci.
Miura et al.













bolic enzymes in a particular cellular location would be a reason-
able and effective way to switch the carbon metabolic pathway.
In addition to hypoxia, higher temperatures (37°C) also in-
duced the Eno2p focus formation. The involvement of high tem-
peratures and hypoxia in the induction of focus formation re-
mains unclear. The finding that focus formation at 37°C was
inhibited by the addition of cycloheximide or rapamycin but not
by the SNF1 knockout mutation suggests 2 possible ways of regu-
lation: via oxygen concentration and by temperature increase.
Postmus et al. recently reported that glycolytic flux was increased
in fermenting S. cerevisiae at 38°C (42). They showed that the
increased activity of glycolytic enzymes did not correlate with pro-
tein abundance and suggested the contribution of posttransla-
tional regulation to enzyme activities. The focus formation by
glycolytic enzymes may be efficient in regulating glycolytic en-
zymes posttranslationally.
The amino acid residues or domains important for the focus
formation by each enzyme could be determined in the sameman-
ner that Eno2p was investigated in this study. The control of the
carbon metabolic pathway in proliferating cells is an important
issue. In particular, enolase and other glycolytic enzymes were
shown to be overproduced in tumor cells in which the glycolysis
rate was increased (80). If spatial reorganization of glycolytic en-
zymes occurs in mammalian cells, the results and methods dem-
onstrated in this study could contribute to clarifying the regula-
tory mechanisms of carbon metabolism in proliferating cells,
including tumor cells.
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